These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R; Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467 [TBL] [Abstract][Full Text] [Related]
8. The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia. Chen Z; Xin Q; Wei W; Wu Y Br J Pharmacol; 2023 Apr; 180(8):1017-1037. PubMed ID: 36623836 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population. Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia. Westers TM; Ossenkoppele GJ; van de Loosdrecht AA Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821 [TBL] [Abstract][Full Text] [Related]
11. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies. Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758 [TBL] [Abstract][Full Text] [Related]
15. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Hales EC; Taub JW; Matherly LH Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475 [TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy and cell therapy for myeloid leukemia]. Yasukawa M Nihon Rinsho; 2009 Oct; 67(10):1938-43. PubMed ID: 19860194 [TBL] [Abstract][Full Text] [Related]
17. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice. Hu Z; Xia J; Fan W; Wargo J; Yang YG Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989 [TBL] [Abstract][Full Text] [Related]
18. Case report: Concomitant Chronic Lymphocytic Leukaemia and Cytogenetically Normal de novo Acute Leukaemia in a Patient. Kajtár B; Rajnics P; Egyed M; Alizadeh H Ann Clin Lab Sci; 2015; 45(5):602-6. PubMed ID: 26586717 [TBL] [Abstract][Full Text] [Related]
19. Cell death by apoptosis in acute leukaemia. Baxter GD; Collins RJ; Harmon BV; Kumar S; Prentice RL; Smith PJ; Lavin MF J Pathol; 1989 Jun; 158(2):123-9. PubMed ID: 2754542 [TBL] [Abstract][Full Text] [Related]
20. An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia. Boeckx N; van der Velden VH; Boogaerts M; Hagemeijer A; Vandenberghe P; van Dongen JJ Haematologica; 2004 Aug; 89(8):ECR28. PubMed ID: 15339697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]